OASIS – FDA approved study design to test BlueWind Medical’s RENOVA iStim system, a batt
June 14, 2018 (Flag Day)
OASIS – Overactive Bladder Stimulation System study will trial 250 patients. Enrollment begins in 2019 and will test efficacy of tibial nerve stim for treatment refractory OAB.
#Trial #iStim #tibialnerve #OveractiveBladder #FDA #OAB #Nervestimulation #RENOVA
0 views